Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-14-006737)

Filing Details

Accession Number:: 0001104659-14-006737
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-05 15:38:45
Reporting Period:: 2014-02-04

Filing Date:: 2014-02-05
Accepted Time:: 2014-02-05 15:38:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1505512	Regulus Therapeutics Inc.	RGLS	Pharmaceutical Preparations (2834)	264738379

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1121404	Sanofi	54 Rue La Boetie Paris I0 75008		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $ 0.001 Par Value-	Acquisiton	2014-02-04	1,303,780	$7.67	5,053,779	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Footnotes

Shares are held directly by Aventis Holdings Inc. an indirectly wholly owned subsidiary of Sanofi. Accordingly, Sanofi can be deemed to share voting and dispositive power over the shares held directly by Aventis Holdings Inc.